Dimensional Fund Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Dimensional Fund Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,314,023	Closed	-$241M	–	3577
2021 Q2	$241M	Sell	1,314,023 -1,917	-0.1%	-$329K	0.08%	267
2021 Q1	$201M	Sell	1,315,940 -4,337	-0.3%	-$671K	0.07%	332
2020 Q4	$206M	Sell	1,320,277 -59,096	-4%	-$7.59M	0.07%	273
2020 Q3	$158M	Buy	1,379,373 +24,456	+2%	+$2.64M	0.07%	292
2020 Q2	$152M	Buy	1,354,917 +132,318	+11%	+$14M	0.07%	293
2020 Q1	$110M	Buy	1,222,599 +390,878	+47%	+$38.4M	0.06%	357
2019 Q4	$89.9M	Buy	831,721 +127,370	+18%	+$13.6M	0.03%	812
2019 Q3	$69M	Buy	704,351 +69,567	+11%	+$7.84M	0.03%	1037
2019 Q2	$83.1M	Buy	634,784 +985	+0.2%	+$127K	0.03%	876
2019 Q1	$85.7M	Sell	633,799 -1,880	-0.3%	-$234K	0.03%	810
2018 Q4	$61.9M	Buy	635,679 +95,895	+18%	+$11.3M	0.03%	1001
2018 Q3	$75M	Buy	539,784 +145,649	+37%	+$18.3M	0.03%	987
2018 Q2	$48.9M	Buy	394,135 +9,694	+3%	+$1.13M	0.02%	1453
2018 Q1	$42.9M	Buy	384,441 +12,402	+3%	+$1.48M	0.02%	1501
2017 Q4	$44.5M	Buy	372,039 +11,333	+3%	+$1.38M	0.02%	1476
2017 Q3	$50.6M	Sell	360,706 -3,562	-1%	-$484K	0.02%	1286
2017 Q2	$44.3M	Buy	364,268 +42,809	+13%	+$4.98M	0.02%	1379
2017 Q1	$39M	Buy	321,459 +13,679	+4%	+$1.76M	0.02%	1458
2016 Q4	$37.7M	Buy	307,780 +1,385	+0.5%	+$169K	0.02%	1442
2016 Q3	$37.5M	Buy	306,395 +9,229	+3%	+$1.19M	0.02%	1356
2016 Q2	$34.7M	Sell	297,166 -4,212	-1%	-$598K	0.02%	1355
2016 Q1	$41.9M	Buy	301,378 +11,593	+4%	+$1.7M	0.03%	1123
2015 Q4	$55.3M	Buy	289,785 +6,189	+2%	+$1.08M	0.03%	763
2015 Q3	$44.3M	Buy	283,596 +3,448	+1%	+$629K	0.03%	920
2015 Q2	$50.6M	Buy	280,148 +30,652	+12%	+$5.29M	0.03%	852
2015 Q1	$43.2M	Buy	249,496 +16,925	+7%	+$3.06M	0.03%	985
2014 Q4	$43M	Buy	232,571 +5,104	+2%	+$946K	0.03%	907
2014 Q3	$37.7M	Buy	227,467 +14,107	+7%	+$2.32M	0.03%	947
2014 Q2	$33.3M	Buy	213,360 +2,249	+1%	+$355K	0.02%	1083
2014 Q1	$32.1M	Buy	211,111 +2,079	+1%	+$331K	0.02%	1047
2013 Q4	$27.8M	Buy	209,032 +743	+0.4%	+$89.2K	0.02%	1156
2013 Q3	$24.2M	Buy	208,289 +1,244	+0.6%	+$136K	0.02%	1193
2013 Q2	$19.1M	Buy	+207,045	New	+$20M	0.02%	1336

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return